Dec 1 (Reuters) - Johnson & Johnson (NYSE:JNJ) JNJ.N :
* JOHNSON & JOHNSON ANNOUNCES INITIATION OF A ROLLING SUBMISSION FOR ITS SINGLE-DOSE JANSSEN COVID-19 VACCINE CANDIDATE WITH HEALTH CANADA
* J&J - HEALTH CANADA ANNOUNCED A ROLLING REVIEW OF INVESTIGATIONAL SINGLE-DOSE JANSSEN COVID-19 VACCINE CANDIDATE